[Results of prolonged treatment of diffuse scleroderma with 6-mercaptopurine].
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013997:Time Factors
D015122:Mercaptopurine
Wyniki przewlekłego leczenia 6-merkaptopuryna chorych z twardzina uogólniona